Location: Cambridge, MA
CIK: 0001400240 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $324M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MRNA | Moderna Inc | 4,632,149 | $137M | 42.2% | $16.43 | +65.3% | COM | 60770K107 |
| SANA | Sana Biotechnology Inc | 25,001,856 | $102M | 31.4% | $32.56 | -86.2% | COM | 799566104 |
| FHTX | Foghorn Therapeutics Inc | 12,674,120 | $68.44M | 21.1% | $19.16 | -76.3% | COM | 344174107 |
| MCRB | Seres Therapeutics Inc | 1,155,850 | $17.24M | 5.3% | $8.80 | +98.2% | COM | 81750R201 |